Help Beta Test Our Site and Be Eligible to Purchase Shares= of=20 Future IPOs In Which We Participate**

eMedsecurities has selected you as a possible participant = to help=20 test our online stock-trading engine for knowledge-based investing = in the=20 life sciences. For your cooperation, you will be eligible = to purchase=20 shares of future IPOs in which we participate, for as long as y= ou=20 maintain your account with us. This is limited to only 50 = qualified=20 testers! Request Mor= e Information.**

eMedsecurities=85 The Cure for the Common Portfolio!

eMedsecurities provides you with a wealth of information, = all=20 compiled in a single, easy-to-use resource. Learn about new r= esearch=20 and upcoming treatments for migraine headache, stroke, epilepsy, br= ain=20 tumor and much more. Obtain critical investment information a= bout the=20 companies that are developing these treatments. eMedsecuritie= s empowers=20 you to make more informed investment decisions. Request More Information.**

Participation i= n eMedsecurities' Beta Test allows you:

Eligibility to purchase s= hares of IPOs in which=20 eMedsecurities participates for as long as you maintain your=20 account**
Valuable research of the = entire product=20 pipeline of companies, including stages of clinical development, = by=20 industry or specific disease
Useful information about = industry trends, recent=20 developments and upcoming IPOs
Commitment to customer se= rvice featuring=20 our Live Customer Service Online
Dedication to fast trade = executions at the best=20 possible price

The following guideline= s will=20 explain what we expect from an eMedsecurities Beta Tester:

Open a funded eMedsecurities=20 account
Visit our online trading site onc= e=20 a week
Execute trades through our web=20 site in accordance with your normal practice
Submit feedback to eMedsecurities= ' development team through a questionnaire sent via=20 email
Provide us with additional=20 feedback regarding the site as needed

The test is limited to = only 50 Beta=20 Testers so sign up now to be considered! Request More Information.**=20

Please note:<= /B> All applications for the Beta Test must be s= ubmitted by January 24, 2001 to be considered.=20

Please=20 be advised that your information will stay in our proprietary datab= ase and=20 will not be sold, traded, given or otherwise provided to outside ve= ndors. We respect your privacy.=20

=20

By=20 submitting your information, you implicitly state that this is some= thing=20 that interests you and that you
agree to receive periodic emails from=20 eMedsecurities.=20

Research indicated= that you=20 might benefit from our offer. To be removed instantly and per= manently from=20 our database, simply click here= . We respect=20 all removal requests.

** R= estrictions=20 Apply: Beta test not open t= o residents of: HI, IL, MI, MN, MS, NE, NH, TN, TX. Initial Public= =20 Offerings are considered speculative investments and as such may no= t be=20 appropriate for every investor. If an investor chooses to participa= te in=20 IPOs, there are certain restrictions that apply: Flipping- The first time an investo= r sells=20 his/her shares within the first 30 days the issue is trading in the= =20 secondary market, that investor will not be allocated shares for th= e next=20 90 days following the sale. The second time that investor =93= flips=94,=20 they will not be allocated IPO shares for 180 days. The third= time=20 that investor =93flips=94, they lose their IPO allocations permanen= tly. Transferring shares- <= /B>If the=20 investor transfers IPO shares out of their account within the first= 30=20 days the issue is trading in the secondary market, they will perman= ently=20 lose their IPO allocations. Beta investors will be chosen = from=20 all the applicants based on their income, net worth and investing=20 experience. IPO shares will only be allocated from transa= ctions in=20 which eMedsecurities participates in the underwriting. A0007-1-A2=20

From owner-ietf-sasl Tue Jan 16 18:59:31 2001 Received: by ns.secondary.com (8.9.3/8.9.3) id SAA10212 for ietf-sasl-bks; Tue, 16 Jan 2001 18:59:31 -0800 (PST) Received: from webserver.onlineevents.com.au ([203.111.80.201]) by ns.secondary.com (8.9.3/8.9.3) with ESMTP id SAA10064; Tue, 16 Jan 2001 18:57:25 -0800 (PST) From: bk12bk27@yahoo.com Received: from max1-34.losangeles.corecomm.net by webserver.onlineevents.com.au with SMTP (Microsoft Exchange Internet Mail Service Version 5.0.1459.44) id C0CGL6NT; Wed, 17 Jan 2001 14:54:31 +1100 DATE: 16 Jan 01 6:44:42 PM Message-ID: SUBJECT: RE; THANK YOU Sender: owner-ietf-sasl@mail.imc.org Precedence: bulk List-Archive: List-ID: List-Unsubscribe: Dear Friend and Partner, Think of all the things you could do if you had more free time and money wasn't an object What kind of car would you be driving? Where would you live? Where would you go on vacation? Now, for a limited time, 300+ money making and saving secrets can be yours for less than $10.00. Click here http://www.300moneysecrets.com/ and ORDER NOW!!!!!!!!!!!!!! Get information now, that could make you millions!!!! ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** To be removed from our mailing list, please email sandywho1212@yahoo.com All REMOVE requests AUTOMATICALLY honored upon receipt. PLEASE understand that any effort to disrupt, close or block this REMOVE account can only result in difficulties for others wanting to be removed from our mailing list as it will be impossible to take anyone off the list if the remove instruction can not be received. From owner-ietf-sasl Fri Jan 19 07:20:17 2001 Received: (from majordomo@localhost) by ns.secondary.com (8.9.3/8.9.3) id HAA20996 for ietf-sasl-bks; Fri, 19 Jan 2001 07:20:17 -0800 (PST) Received: from cins.hanyang.ac.kr ([166.104.204.187]) by ns.secondary.com (8.9.3/8.9.3) with ESMTP id HAA19964; Fri, 19 Jan 2001 07:17:09 -0800 (PST) From: emed11@libero.it Received: by cins.hanyang.ac.kr id XAA372399; Fri, 19 Jan 2001 23:57:34 +0900 (KST) Subject: Obtain Biotech IPOs! 206 Date: Fri, 19 Jan 2001 10:20:59 Message-Id: <795.102790.325792@libero.it> Reply-To: emed11@libero.it Mime-Version: 1.0 Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable X-MIME-Autoconverted: from 8bit to quoted-printable by cins.hanyang.ac.kr id XAA372399 Sender: owner-ietf-sasl@mail.imc.org Precedence: bulk List-Archive: List-ID: List-Unsubscribe:

Help Beta Test Our Site and Be Eligible to Purchase Shares= of=20 Future IPOs In Which We Participate**

eMedsecurities=85 The Cure for the Common Portfolio!

Participation i= n eMedsecurities' Beta Test allows you:

Eligibility to purchase s= hares of IPOs in which=20 eMedsecurities participates for as long as you maintain your=20 account**
Valuable research of the = entire product=20 pipeline of companies, including stages of clinical development, = by=20 industry or specific disease
Useful information about = industry trends, recent=20 developments and upcoming IPOs
Commitment to customer se= rvice featuring=20 our Live Customer Service Online
Dedication to fast trade = executions at the best=20 possible price

The following guideline= s will=20 explain what we expect from an eMedsecurities Beta Tester:

Open a funded eMedsecurities=20 account
Visit our online trading site onc= e=20 a week
Execute trades through our web=20 site in accordance with your normal practice
Submit feedback to eMedsecurities= ' development team through a questionnaire sent via=20 email
Provide us with additional=20 feedback regarding the site as needed

The test is limited to = only 50 Beta=20 Testers so sign up now to be considered! Request More Information.**=20

Please note:<= /B> All applications for the Beta Test must be s= ubmitted by January 24, 2001 to be considered.=20

Please=20 be advised that your information will stay in our proprietary datab= ase and=20 will not be sold, traded, given or otherwise provided to outside ve= ndors. We respect your privacy.=20

=20

By=20 submitting your information, you implicitly state that this is some= thing=20 that interests you and that you
agree to receive periodic emails from=20 eMedsecurities.=20

Research indicated= that you=20 might benefit from our offer. To be removed instantly and per= manently from=20 our database, simply click here= . We respect=20 all removal requests.

Received: (from majordomo@localhost) by ns.secondary.com (8.9.3/8.9.3) id HAA20996 for ietf-sasl-bks; Fri, 19 Jan 2001 07:20:17 -0800 (PST) Received: from cins.hanyang.ac.kr ([166.104.204.187]) by ns.secondary.com (8.9.3/8.9.3) with ESMTP id HAA19964; Fri, 19 Jan 2001 07:17:09 -0800 (PST) From: emed11@libero.it Received: by cins.hanyang.ac.kr id XAA372399; Fri, 19 Jan 2001 23:57:34 +0900 (KST) Subject: Obtain Biotech IPOs! 206 Date: Fri, 19 Jan 2001 10:20:59 Message-Id: <795.102790.325792@libero.it> Reply-To: emed11@libero.it Mime-Version: 1.0 Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable X-MIME-Autoconverted: from 8bit to quoted-printable by cins.hanyang.ac.kr id XAA372399 Sender: owner-ietf-sasl@mail.imc.org Precedence: bulk List-Archive: List-ID: List-Unsubscribe:

Help Beta Test Our Site and Be Eligible to Purchase Shares= of=20 Future IPOs In Which We Participate**

eMedsecurities=85 The Cure for the Common Portfolio!

Participation i= n eMedsecurities' Beta Test allows you:

Eligibility to purchase s= hares of IPOs in which=20 eMedsecurities participates for as long as you maintain your=20 account**
Valuable research of the = entire product=20 pipeline of companies, including stages of clinical development, = by=20 industry or specific disease
Useful information about = industry trends, recent=20 developments and upcoming IPOs
Commitment to customer se= rvice featuring=20 our Live Customer Service Online
Dedication to fast trade = executions at the best=20 possible price

The following guideline= s will=20 explain what we expect from an eMedsecurities Beta Tester:

Open a funded eMedsecurities=20 account
Visit our online trading site onc= e=20 a week
Execute trades through our web=20 site in accordance with your normal practice
Submit feedback to eMedsecurities= ' development team through a questionnaire sent via=20 email
Provide us with additional=20 feedback regarding the site as needed

The test is limited to = only 50 Beta=20 Testers so sign up now to be considered! Request More Information.**=20

Please note:<= /B> All applications for the Beta Test must be s= ubmitted by January 24, 2001 to be considered.=20

Please=20 be advised that your information will stay in our proprietary datab= ase and=20 will not be sold, traded, given or otherwise provided to outside ve= ndors. We respect your privacy.=20

=20

By=20 submitting your information, you implicitly state that this is some= thing=20 that interests you and that you
agree to receive periodic emails from=20 eMedsecurities.=20

Research indicated= that you=20 might benefit from our offer. To be removed instantly and per= manently from=20 our database, simply click here= . We respect=20 all removal requests.

Received: by ns.secondary.com (8.9.3/8.9.3) id SAA10212 for ietf-sasl-bks; Tue, 16 Jan 2001 18:59:31 -0800 (PST) Received: from webserver.onlineevents.com.au ([203.111.80.201]) by ns.secondary.com (8.9.3/8.9.3) with ESMTP id SAA10064; Tue, 16 Jan 2001 18:57:25 -0800 (PST) From: bk12bk27@yahoo.com Received: from max1-34.losangeles.corecomm.net by webserver.onlineevents.com.au with SMTP (Microsoft Exchange Internet Mail Service Version 5.0.1459.44) id C0CGL6NT; Wed, 17 Jan 2001 14:54:31 +1100 DATE: 16 Jan 01 6:44:42 PM Message-ID: SUBJECT: RE; THANK YOU Sender: owner-ietf-sasl@mail.imc.org Precedence: bulk List-Archive: List-ID: List-Unsubscribe: Dear Friend and Partner, Think of all the things you could do if you had more free time and money wasn't an object What kind of car would you be driving? Where would you live? Where would you go on vacation? Now, for a limited time, 300+ money making and saving secrets can be yours for less than $10.00. Click here http://www.300moneysecrets.com/ and ORDER NOW!!!!!!!!!!!!!! Get information now, that could make you millions!!!! ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** To be removed from our mailing list, please email sandywho1212@yahoo.com All REMOVE requests AUTOMATICALLY honored upon receipt. PLEASE understand that any effort to disrupt, close or block this REMOVE account can only result in difficulties for others wanting to be removed from our mailing list as it will be impossible to take anyone off the list if the remove instruction can not be received.